DVA Earnings

DVA reported its earnings on 2026-02-02, showcasing a revenue of 3.62B against an estimate of 3.53B, resulting in a 2.54% surprise. The EPS was 3.4, surpassing the expected 3.24 by 4.94%. The stock experienced a 21.17% price change on the earnings day and a 26.66% change over the next five days, reflecting market reactions to the results.

Following DVA's earnings announcement on 2026-02-02, the stock price moved by 21.17% on the day of the release. Over the subsequent five days, it saw a 26.66% change. Historically, DVA's stock price tends to shift by an average of -1.32% in the 10 days leading up to earnings and 4.77% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate DVA's annual revenue to reach 3.35B, while the EPS is projected at 2.46. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between DVA's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, DVA's stock price typically moves by -1.32% in the 10 days before its earnings and 4.77% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 2.46 and revenue of 3.35B.

The earnings call presents mixed signals. While the company has achieved milestones, such as the first profitable year for IKC and strong international growth, challenges remain. The Q&A highlights concerns about ACA headwinds, missed treatments, and uncertainty in patient volume growth. Management's unclear responses to certain questions add to the uncertainty. Although there are positive elements, like reaffirmed guidance and strategic investments, the mixed financial outlook and external challenges suggest a neutral stock price movement in the short term.